Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000

Authors: Critchley, Ian A., Blosser, Renée S., Karlowsky, James A., Yamakita, Juri, Barth, Alfonso, Sader, Helio S., Mendes, Caio, Teixeira, Lucia, Rossi, Flavia, Dias, Cicero A. C., Jones, Mark E., Thornsberry, Clyde, Sahm, Daniel F.

Source: Brazilian Journal of Infectious Diseases. December 2001 5(6)

Subject Terms: Streptococcus pneumoniae, antimicrobial resistance, surveillance study, respiratory pathogen

File Description: text/html

Access URL: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702001000600002

Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013-2015

Authors: Karlowsky, James A., Hoban, Daryl J., Hackel, Meredith A., Lob, Sibylle H., Sahm, Daniel F.

Source: Brazilian Journal of Infectious Diseases. June 2017 21(3)

Subject Terms: Surveillance, SMART, Imipenem, Ertapenem

File Description: text/html

Access URL: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702017000300343

Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018–2022

Authors: Wise, Mark G., Karlowsky, James A., Mohamed, Naglaa, Hermsen, Elizabeth D., Kamat, Shweta, Townsend, Andy, Brink, Adrian, Soriano, Alex, Paterson, David L., Moore, Luke S.P., Sahm, Daniel F.

Source: In Journal of Global Antimicrobial Resistance June 2024 37:168-175

Susceptibility of gram-negative isolates collected in Taiwan to imipenem/relebactam and comparator agents – SMART 2018–2021

Authors: Wise, Mark G., Karlowsky, James A., Chen, Wei-Ting, Siddiqui, Fakhar, Young, Katherine, Motyl, Mary R., Sahm, Daniel F.

Source: In Journal of the Formosan Medical Association March 2024 123(3):400-407

In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa from sub-Saharan Africa: ATLAS Global Surveillance Program 2017–2021

Authors: Wise, Mark G., Karlowsky, James A., Hackel, Meredith A., Harti, Mohamed Amine, Ntshole, Bontle M.E., Njagua, Eva Njeri, Oladele, Rita, Samuel, Catherine, Khan, Shameema, Wadula, Jeannette, Lowman, Warren, Lembede, Busisani W., Sahm, Daniel F.

Source: In Journal of Global Antimicrobial Resistance December 2023 35:93-100

Carbapenem resistance among Gram-negative isolates collected from patients in ICU and non-ICU hospital wards in Hong Kong: SMART 2017–2020

Authors: Karlowsky, James A., Lob, Sibylle H., Khan, Tsz K., Chen, Wei-Ting, Woo, Patrick C.Y., Seto, Wing Hong, Ip, Margaret, Leung, Stanley W.M., Wong, Queenie W.-L., Chau, Rene W.Y., DeRyke, C. Andrew, Young, Katherine, Motyl, Mary R., Sahm, Daniel F.

Source: Journal of global antimicrobial resistance. 33:260-266

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100193377182.0x000001&indx=1&recIds=ETOCvdc_100193377182.0x000001

In Vitro Activity of Cefiderocol Against Meropenem-Nonsusceptible Gram-Negative Bacilli with Defined β-Lactamase Carriage: SIDERO-WT Surveillance Studies, 2014–2019

Authors: Wise, Mark G., Karlowsky, James A., Hackel, Meredith A., Takemura, Miki, Yamano, Yoshinori, Echols, Roger, Sahm, Daniel F.

Source: MICROBIAL DRUG RESISTANCE -NEW YORK. 29(8):360-370

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100188873177.0x000001&indx=1&recIds=ETOCvdc_100188873177.0x000001

In vitro antibacterial activities of cefiderocol against Gram-negative clinical strains isolated from China in 2020

Authors: Kohira, Naoki, Hackel, Meredith A, Oota, Merime, Takemura, Miki, Hu, Fupin, Mizuno, Hiromichi, Sahm, Daniel F, Yamano, Yoshinori

Source: Journal of global antimicrobial resistance. 32:181-186

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100185812501.0x000001&indx=1&recIds=ETOCvdc_100185812501.0x000001

Temporal and geographical prevalence of carbapenem-resistant Pseudomonas aeruginosa and the in vitro activity of ceftolozane/tazobactam and comparators in Taiwan—SMART 2012–2021

Authors: Karlowsky, James A., Wise, Mark G., Hsieh, Tai-Chin, Lu, Hung-Chi, Chen, Wei-Ting, Cheng, Ming-Huei, Siddiqui, Fakhar, Young, Katherine, Motyl, Mary R., Sahm, Daniel F.

Source: In Journal of Global Antimicrobial Resistance September 2023 34:106-112

In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in the Asia-Pacific region: SMART 2017-2020

Authors: Karlowsky, James A., Lob, Sibylle H., Chen, Wei-Ting, DeRyke, C. Andrew, Siddiqui, Fakhar, Young, Katherine, Motyl, Mary R., Sahm, Daniel F.

Source: In International Journal of Antimicrobial Agents September 2023 62(3)

In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018‒2020

Authors: Karlowsky, James A., Lob, Sibylle H., Siddiqui, Fakhar, Pavia, Jacqueline, DeRyke, C. Andrew, Young, Katherine, Motyl, Mary R., Sahm, Daniel F.

Source: In Brazilian Journal of Infectious Diseases May-June 2023 27(3)

Epidemiology and in vitro activity of ceftazidime-avibactam and comparator agents against multidrug-resistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020

Authors: Wise, Mark G., Karlowsky, James A., Lemos-Luengas, Elkin V., Valdez, Rafael R., Sahm, Daniel F.

Source: In Brazilian Journal of Infectious Diseases May-June 2023 27(3)

In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020

Authors: Karlowsky, James A., Lob, Sibylle H., Siddiqui, Fakhar, Akrich, Brune, DeRyke, C. Andrew, Young, Katherine, Motyl, Mary R., Hawser, Stephen P., Sahm, Daniel F.

Source: In International Journal of Antimicrobial Agents May 2023 61(5)

Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa – Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020

Authors: Lob, Sibylle H., Estabrook, Mark A., DeRyke, C. Andrew, Alekseeva, Irina, Siddiqui, Fakhar, Young, Katherine, Motyl, Mary R., Sahm, Daniel F.

Source: In International Journal of Infectious Diseases December 2022 125:250-257

Antimicrobial susceptibility testing of clinical isolates of Gram-negative bacilli collected in Morocco by the ATLAS Global Surveillance Program from 2018 to 2020

Authors: Karlowsky, James A., Bouchillon, Samuel K., Benaouda, Amina, Soraa, Nabila, Zerouali, Khalid, Mohamed, Naglaa, Alami, Taha, Sahm, Daniel F.

Source: In Journal of Global Antimicrobial Resistance September 2022 30:23-30

In vitro activity of ceftolozane/tazobactam against Gram‐negative isolates collected from ICU patients with lower respiratory tract infections in seven Asian countries—SMART 2017–2019

Authors: Lob, Sibylle H., Kazmierczak, Krystyna M., Chen, Wei-Ting, Siddiqui, Fakhar, DeRyke, C. Andrew, Young, Katherine, Motyl, Mary R., Sahm, Daniel F.

Source: In Journal of Global Antimicrobial Resistance June 2022 29:527-533

Prevalence of ESBL non-CRE Escherichia coli and Klebsiella pneumoniae among clinical isolates collected by the SMART global surveillance programme from 2015 to 2019

Authors: Karlowsky, James A. ^{a, b}, Lob, Sibylle H. ^{a, ⁎}, DeRyke, C. Andrew ^c, Siddiqui, Fakhar ^c, Young, Katherine ^c, Motyl, Mary R. ^c, Sahm, Daniel F. ^a

Source: In International Journal of Antimicrobial Agents March 2022 59(3)

In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017–2019

Authors: Karlowsky, James A., Kazmierczak, Krystyna M., Valente, Maria Lavínea Novis de Figueiredo, Luengas, Elkin Lemos, Baudrit, Monique, Quintana, Alvaro, Irani, Paurus, Stone, Gregory G., Sahm, Daniel F.

Source: In Brazilian Journal of Infectious Diseases November-December 2021 25(6)

In vitro activity of ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in the Middle East and Africa: AWARE global surveillance programme 2015–2018

Authors: Karlowsky, James A., Hackel, Meredith A., Bouchillon, Samue l K., Lowman, Warren, Kotb, Ramy El Mahdy, Mohamed, Naglaa, Stone, Gregory G., Sahm, Daniel F.

Source: In Journal of Global Antimicrobial Resistance March 2021 24:249-256

Antimicrobial Activity of Imipenem/Relebactam and Comparator Agents Against Gram-Negative Isolates Collected From Pediatric Patients: SMART 2018–2022 Global Surveillance.

Authors: DeRyke, C Andrew, Wise, Mark G, Bauer, Karri A, Siddiqui, Fakhar, Young, Katherine, Motyl, Mary R, Sahm, Daniel F

Source: Journal of the Pediatric Infectious Diseases Society; Jan2025, Vol. 14 Issue 1, p1-9, 9p

Subject Terms: ANTIBIOTICS, IN vitro studies, PUBLIC health surveillance, RESEARCH funding, DESCRIPTIVE statistics, PEDIATRICS, ENTEROBACTERIACEAE, IMIPENEM, GRAM-negative bacterial diseases, PHYSICIANS, PSEUDOMONAS, GRAM-negative bacteria, PHARMACODYNAMICS

Geographic Terms: NEW Jersey